Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-02-08
1996-09-10
Higel, Floyd D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514424, 514650, 514652, 514653, A61K 31405, A61K 31135
Patent
active
055546404
ABSTRACT:
This invention provides a method of selectively antagonizing-the 5-HT.sub.1A receptor in mammals by administering aryloxypropanolamines. Aryloxypropanolamines are also claimed.
REFERENCES:
patent: 3337628 (1967-08-01), Crowther et al.
patent: 3415873 (1968-12-01), Stevens
patent: 3471515 (1969-10-01), Troxler et al.
patent: 3534086 (1970-10-01), Narayanan et al.
patent: 3551493 (1970-12-01), Ruschig et al.
patent: 3696120 (1972-10-01), Troxler
patent: 4157400 (1979-06-01), Mardiguian
patent: 4229464 (1980-10-01), Kampe et al.
patent: 4304915 (1981-12-01), Berthold
patent: 4463190 (1984-07-01), Lunsford et al.
patent: 4564625 (1986-01-01), Muschaweck et al.
patent: 5013761 (1991-05-01), Beedle et al.
Crowther, et al II, J. Med. Chem., 11, 1009-1013 (1968).
Middlemiss I, Eur. J. Pharmacology, 120, 51-56 (1986).
Schlicker, et al., Naunyl-Schmiedeberg's Arch. Pharmacol., 331, 398-401 (1985).
Edwards, et al., Neuropharmacology, 26 (1), 93-96 (1987).
Maura, et al., Neuropharmacology, 26 (7A), 713-717 (1987).
Alexander, et al., J. Pharm. Pharmacol., 39, 664-666 (1987).
Middlemiss II, Ann. Rept. in Med. Chem., 21, 41-50 (1986).
Fuller, Monographs in Neural Sciences, 10, 158-181 (1984).
Glennon, J. Med. Chem., 30 (1), 1-12 (1987).
Traber, et al., TIPS, 8, 432-437 (1987).
Gorodinskaya I, et al., Chemical Abstracts, 74(3):11638 (1971).
Guzzi, et al., Chemical Abstracts, 114(9):81275 (1989).
Vejdelek, et al., Chemical Abstracts, 113(23):211806 (1990).
Gal, et al., Chemical Abstracts, 103(7):47763 (1985).
Beedle, et al., Chemical Abstracts, 113(1):564 (1988).
Gorodinskaya, Chemical Abstracts, 70(23):104981 (1969).
Crowther, et al. III, Chemical Abstracts, 70(9):37543 (1969).
Simon, et al., Chemical Abstracts, 69:106302 (1968).
Gorodinskaya, et al. II, Chemical Abstracts, 76: 135535 (1972).
Pitah, et al., J. Med. Chem., 30, 612-615 (1987).
Milecki, et al., J. Med. Chem., 30, 1563-1566 (1987).
Beedle Edward E.
Robertson David W.
Wong David T.
Eli Lilly and Company
Higel Floyd D.
Jones Joseph A.
LandOfFree
Use of propanolamine derivatives as selective 5-HT.sub.1 antagon does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of propanolamine derivatives as selective 5-HT.sub.1 antagon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of propanolamine derivatives as selective 5-HT.sub.1 antagon will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1320852